tiprankstipranks
Cellectis S.A. (CLLS)
:CLLS
US Market

Cellectis SA (CLLS) Stock Investors

Compare
930 Followers
Based on 793,101 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLLS
On average, investors allocate 0.00% of their portfolios to CLLS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,101 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLLS

4.0%
Last 7
Days
1.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLLS, out of 793,101 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLLS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.17%
$1.59
Based on the activity of investors who made their portfolios public
The table shows changes in CLLS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLLS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
3.70%
+0.12%
-0.66%
38.77B
Technology
Intuitive Surgical
3.53%
+1.53%
+1.11%
176.45B
Healthcare
Nio
8.94%
-0.62%
-4.69%
9.25B
Consumer Cyclical
Spotify
5.22%
+1.19%
-1.31%
121.42B
Communication Services
Viking Therapeutics
3.95%
-0.48%
-6.81%
3.29B
Healthcare
PDD Holdings
4.95%
-0.56%
-5.66%
177.93B
Consumer Cyclical
Zscaler
3.47%
-0.73%
-5.16%
31.75B
Technology
Bristol-Myers Squibb
3.57%
-0.23%
-3.30%
123.93B
Healthcare
CVS Health
4.34%
-0.21%
-4.94%
84.54B
Healthcare
Abbott Laboratories
3.43%
-0.29%
-3.92%
219.11B
Healthcare
Based on the activity of 793,101 active portfolios
Open your Smart Portfolio

CLLS Investor Analysis

CLLS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of CLLS holders
are under 35
Average Segment Performance
Average P/E Ratio18.15
Beta11.20
Dividend Yield3.92%
CLLS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
51.9%
of CLLS holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.89
Beta22.53
Dividend Yield3.38%
CLLS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
37.0%
of CLLS holders
are over 55
Average Segment Performance
Average P/E Ratio13.53
Beta11.97
Dividend Yield3.63%
Overview of age group and performance of CLLS stock investors
See who invests in CLLS according to age group and performance.

FAQ

How many retail Investors hold CLLS?
<0.1% of TipRanks' retail investors hold CLLS in their portfolios.
    What is CLLS Investor Sentiment?
    CLLS’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of CLLS in the last 7 days?
      ▼ 4.0% of TipRanks' retail investors changed their holding of CLLS in the last 7 days.
        What percentage of retail investors changed their holding of CLLS in the last 30 days?
        ▼ 1.0% of TipRanks' retail investors changed their holding of CLLS in the last 30 days.
          What is the average age of retail investors who hold CLLS?
          The average age of CLLS Holders is between 35–55.
            What other stocks have CLLS investors also bought?
            CLLS Investors also bought XYZ, ISRG, NIO, SPOT, VKTX, PDD, ZS, BMY, CVS, ABT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALGNAlign Tech
              ALKSAlkermes
              AZNAstraZeneca
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis